These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 24645313

  • 1. [Activation of Kupffer cell and related signal pathway proteins in the liver of high fat and high fructose diet induced NAFLD mice].
    Zhu ML, Liu J, Liu YL, Yang WJ, Luo Y, Zhuang ZJ, Jiao QB, Chen JY, Yan J, Bian DX, Ma XJ, Xun YH, Shi JP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):325-7. PubMed ID: 24645313
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I.
    Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M, Nishio Y, Sekine O, Nagai Y, Maeno Y, Ugi S, Yoshizaki T, Morino K, Kume S, Kashiwagi A, Maegawa H.
    Am J Physiol Endocrinol Metab; 2013 Jul 15; 305(2):E293-304. PubMed ID: 23715726
    [Abstract] [Full Text] [Related]

  • 6. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
    Wada T, Miyashita Y, Sasaki M, Aruga Y, Nakamura Y, Ishii Y, Sasahara M, Kanasaki K, Kitada M, Koya D, Shimano H, Tsuneki H, Sasaoka T.
    Am J Physiol Endocrinol Metab; 2013 Dec 01; 305(11):E1415-25. PubMed ID: 24129399
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 01; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 8. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J, Liu Y, Wang W, Luo Y, Zhuang Z, Jiao Q, Chen J, Bian D, Ma X, Xun Y, Zhu M, Shi J.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun 01; 22(6):445-50. PubMed ID: 25203709
    [Abstract] [Full Text] [Related]

  • 9. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW.
    World J Gastroenterol; 2016 Sep 21; 22(35):8026-40. PubMed ID: 27672297
    [Abstract] [Full Text] [Related]

  • 10. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.
    Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, Pecker F, Tran A, Gual P, Mallat A, Lotersztajn S, Pavoine C.
    Hepatology; 2014 Jan 21; 59(1):130-42. PubMed ID: 23832548
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL, Lee IP, Zhou M, Wong JY, Hui X, Xu A, Lam KS.
    J Hepatol; 2013 Feb 21; 58(2):358-64. PubMed ID: 23108115
    [Abstract] [Full Text] [Related]

  • 12. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
    Crescenzo R, Bianco F, Coppola P, Mazzoli A, Tussellino M, Carotenuto R, Liverini G, Iossa S.
    Exp Physiol; 2014 Sep 21; 99(9):1203-13. PubMed ID: 24972835
    [Abstract] [Full Text] [Related]

  • 13. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
    Chen XM, Li FQ, Yan S, Wu XC, Tang CL.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct 18; 48(5):777-782. PubMed ID: 27752155
    [Abstract] [Full Text] [Related]

  • 14. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
    Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, Gärttner S, Spruss A, Huber O, Bergheim I.
    J Nutr Biochem; 2015 Nov 18; 26(11):1183-92. PubMed ID: 26168700
    [Abstract] [Full Text] [Related]

  • 15. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.
    Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I.
    J Nutr Biochem; 2011 Jun 18; 22(6):527-34. PubMed ID: 20801629
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.
    Liver Int; 2011 Oct 18; 31(9):1285-97. PubMed ID: 21745271
    [Abstract] [Full Text] [Related]

  • 17. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice.
    Xu R, Tao A, Zhang S, Zhang M.
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep 18; 45(9):726-33. PubMed ID: 23786840
    [Abstract] [Full Text] [Related]

  • 18. Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet.
    Jang SA, Lee S, Sohn EH, Yang J, Park DW, Jeong YJ, Kim I, Kwon JE, Song HS, Cho YM, Meng X, Koo HJ, Kang SC.
    Nutr Res; 2016 Sep 18; 36(9):914-924. PubMed ID: 27632911
    [Abstract] [Full Text] [Related]

  • 19. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
    Scorletti E, Byrne CD.
    Annu Rev Nutr; 2013 Sep 18; 33():231-48. PubMed ID: 23862644
    [Abstract] [Full Text] [Related]

  • 20. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
    Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J, Hou YJ, Chang YX, Tu QQ, Feng GS, Shen F, Wu MC, Wang HY.
    Hepatology; 2011 Nov 18; 54(5):1620-30. PubMed ID: 21809356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.